Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,759 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Adverse Effects of Immune Checkpoint Inhibitors (Programmed Death-1 Inhibitors and Cytotoxic T-Lymphocyte-Associated Protein-4 Inhibitors): Results of a Retrospective Study.
Bajwa R, Cheema A, Khan T, Amirpour A, Paul A, Chaughtai S, Patel S, Patel T, Bramson J, Gupta V, Levitt M, Asif A, Hossain MA. Bajwa R, et al. Among authors: patel t, patel s. J Clin Med Res. 2019 Apr;11(4):225-236. doi: 10.14740/jocmr3750. Epub 2019 Mar 18. J Clin Med Res. 2019. PMID: 30937112 Free PMC article. Review.
Prevalence of chronic kidney disease among patients undergoing transradial percutaneous coronary interventions.
Hossain MA, Quinlan A, Heck-Kanellidis J, Calderon D, Patel T, Gandhi B, Patel S, Hetavi M, Costanzo EJ, Cosentino J, Patel C, Dewan A, Kuo YH, Salman L, Vachharajani TJ. Hossain MA, et al. Among authors: patel t, patel s, patel c. J Vasc Access. 2018 Jul;19(4):346-349. doi: 10.1177/1129729817752874. Epub 2018 Mar 12. J Vasc Access. 2018. PMID: 29529964
A Two-Stage Training Framework Using Multicontrast MRI Radiomics for IDH Mutation Status Prediction in Glioma.
Truong NCD, Bangalore Yogananda CG, Wagner BC, Holcomb JM, Reddy D, Saadat N, Hatanpaa KJ, Patel TR, Fei B, Lee MD, Jain R, Bruce RJ, Pinho MC, Madhuranthakam AJ, Maldjian JA. Truong NCD, et al. Among authors: patel tr. Radiol Artif Intell. 2024 May 22:e230218. doi: 10.1148/ryai.230218. Online ahead of print. Radiol Artif Intell. 2024. PMID: 38775670
Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trial.
Coutts SB, Ankolekar S, Appireddy R, Arenillas JF, Assis Z, Bailey P, Barber PA, Bazan R, Buck BH, Butcher KS, Camden MC, Campbell B, Casaubon LK, Catanese L, Chatterjee K, Choi PMC, Clarke B, Dowlatshahi D, Ferrari J, Field TS, Ganesh A, Ghia D, Goyal M, Greisenegger S, Halse O, Horn M, Hunter G, Imoukhuede O, Kelly PJ, Kennedy J, Kenney C, Kleinig TJ, Krishnan K, Lima F, Mandzia JL, Marko M, Martins SO, Medvedev G, Menon BK, Mishra SM, Molina C, Moussaddy A, Muir KW, Parsons MW, Penn AMW, Pille A, Pontes-Neto OM, Roffe C, Serena J, Simister R, Singh N, Spratt N, Strbian D, Tham CH, Wiggam MI, Williams DJ, Willmot MR, Wu T, Yu AYX, Zachariah G, Zafar A, Zerna C, Hill MD; TEMPO-2 investigators. Coutts SB, et al. Lancet. 2024 May 16:S0140-6736(24)00921-8. doi: 10.1016/S0140-6736(24)00921-8. Online ahead of print. Lancet. 2024. PMID: 38768626
2,759 results